Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-05-18 to 2022-06-09
Current total value of award: $1276.04
Description: 4557321736!ZOLADEX 3.6 MG IMPLANT SYRNS